Document is current
Any future updates will be listed below
-
Authors
Stewart-Morgan, Kathleen R. https://orcid.org/0000-0001-7570-6217
Requena, Cristina E. https://orcid.org/0000-0001-5239-9162
Flury, Valentin https://orcid.org/0000-0003-0476-4940
Du, Qian
Heckhausen, Zoe https://orcid.org/0000-0003-0085-2492
Hajkova, Petra https://orcid.org/0000-0003-4145-1468
Groth, Anja https://orcid.org/0000-0003-0577-1771
- License Information
-
More Information
Article History
Received: 6 January 2022
Accepted: 10 November 2022
First Online: 12 January 2023
Competing interests
: A.G. is co-founder and chief scientific officer (CSO) of ANKRIN Therapeutics. The remaining authors declare no competing interests.
